GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.
Related Posts
The Fallout from Trump’s Reign of Tariffs
Global markets were in a tailspin on Thursday as policymakers and trade partners expressed dismay over president’s latest trade-war salvo.
As Markets Whipsaw, Conservative Media Shrugs
Many conservative websites have either ignored the recent stock declines or framed them in a positive way.
Trump’s Tariffs on Steel and Aluminum Take Effect
President Trump imposed a 25 percent tariff on metal imports. The move is expected to raise costs for U.S. manufacturers of cars, solar panels and […]